Collegium Pharmaceutical Inc
NASDAQ:COLL

Watchlist Manager
Collegium Pharmaceutical Inc Logo
Collegium Pharmaceutical Inc
NASDAQ:COLL
Watchlist
Price: 31.77 USD -0.72% Market Closed
Market Cap: 1B USD

Relative Value

The Relative Value of one COLL stock under the Base Case scenario is 66.51 USD. Compared to the current market price of 31.77 USD, Collegium Pharmaceutical Inc is Undervalued by 52%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

COLL Relative Value
Base Case
66.51 USD
Undervaluation 52%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
76
vs Industry
60
Median 3Y
1.7
Median 5Y
2
Industry
2.5
Forward
1.3
vs History
20
vs Industry
33
Median 3Y
12.3
Median 5Y
12.5
Industry
21.6
Forward
4.5
vs History
57
vs Industry
48
Median 3Y
4.5
Median 5Y
6.1
Industry
16.7
vs History
41
vs Industry
33
Median 3Y
5.6
Median 5Y
4.6
Industry
24
vs History
33
vs Industry
17
Median 3Y
4.2
Median 5Y
4
Industry
2.2
vs History
46
vs Industry
43
Median 3Y
2.4
Median 5Y
2.4
Industry
2.7
Forward
2.1
vs History
55
vs Industry
47
Median 3Y
4.1
Median 5Y
4.3
Industry
5.3
vs History
55
vs Industry
47
Median 3Y
4.7
Median 5Y
5.5
Industry
12.9
Forward
3.6
vs History
44
vs Industry
39
Median 3Y
10.1
Median 5Y
11.9
Industry
16.3
Forward
5.2
vs History
41
vs Industry
43
Median 3Y
7.4
Median 5Y
7.7
Industry
15.2
vs History
11
vs Industry
34
Median 3Y
4.5
Median 5Y
4.5
Industry
17.7
vs History
68
vs Industry
55
Median 3Y
1.2
Median 5Y
1.3
Industry
1.9

Multiples Across Competitors

COLL Competitors Multiples
Collegium Pharmaceutical Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Collegium Pharmaceutical Inc
NASDAQ:COLL
1B USD 1.5 23.3 5 12.2
US
Eli Lilly and Co
NYSE:LLY
748.5B USD 15.3 67.4 36.2 39.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
396.4B USD 4.4 18.2 13.3 17.4
DK
Novo Nordisk A/S
CSE:NOVO B
1.9T DKK 6.3 18.2 12.6 14.5
CH
Roche Holding AG
SIX:ROG
204.2B CHF 3.4 24.6 9.3 10.9
CH
Novartis AG
SIX:NOVN
184.5B CHF 4.3 17.8 10.6 14.1
UK
AstraZeneca PLC
LSE:AZN
162.1B GBP 3.9 27.9 130.7 197.1
US
Merck & Co Inc
NYSE:MRK
207.4B USD 3.2 11.9 8.8 10.7
IE
Endo International PLC
LSE:0Y5F
183.8B USD 79.3 -62.9 292.4 733.2
US
Pfizer Inc
NYSE:PFE
139.9B USD 2.2 17.7 7.6 10.7
P/E Multiple
Earnings Growth PEG
US
Collegium Pharmaceutical Inc
NASDAQ:COLL
Average P/E: 25.2
23.3
43%
0.5
US
Eli Lilly and Co
NYSE:LLY
67.4
49%
1.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
18.2
27%
0.7
DK
Novo Nordisk A/S
CSE:NOVO B
18.2
18%
1
CH
Roche Holding AG
SIX:ROG
24.6
32%
0.8
CH
Novartis AG
SIX:NOVN
17.8
17%
1
UK
AstraZeneca PLC
LSE:AZN
27.9
36%
0.8
US
Merck & Co Inc
NYSE:MRK
11.9
17%
0.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -62.9 N/A N/A
US
Pfizer Inc
NYSE:PFE
17.7
30%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Collegium Pharmaceutical Inc
NASDAQ:COLL
Average EV/EBITDA: 397.5
5
4%
1.2
US
Eli Lilly and Co
NYSE:LLY
36.2
30%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
13.3
7%
1.9
DK
Novo Nordisk A/S
CSE:NOVO B
12.6
13%
1
CH
Roche Holding AG
SIX:ROG
9.3
5%
1.9
CH
Novartis AG
SIX:NOVN
10.6
5%
2.1
UK
AstraZeneca PLC
LSE:AZN
130.7
10%
13.1
US
Merck & Co Inc
NYSE:MRK
8.8
8%
1.1
IE
E
Endo International PLC
LSE:0Y5F
292.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
2%
3.8
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Collegium Pharmaceutical Inc
NASDAQ:COLL
Average EV/EBIT: 1 705.7
12.2
30%
0.4
US
Eli Lilly and Co
NYSE:LLY
39.5
32%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
17.4
13%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
14.5
14%
1
CH
Roche Holding AG
SIX:ROG
10.9
6%
1.8
CH
Novartis AG
SIX:NOVN
14.1
10%
1.4
UK
AstraZeneca PLC
LSE:AZN
197.1
23%
8.6
US
Merck & Co Inc
NYSE:MRK
10.7
11%
1
IE
E
Endo International PLC
LSE:0Y5F
733.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.7
10%
1.1